Salicyladehyde

Salicyladehyde

SCHEMBL5555583

CC(C)[C@H](N)C(=O)O.O=Cc1ccccc1O

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRIM24 O15164 1/20 0.58
TRIM33 Q9UPN9 1/20 0.58
SLC7A5 Q01650 1/20 0.48
CA1 P00915 2/20 0.42
CA2 P00918 2/20 0.42
NFKB1 P19838 2/20 0.42
CA4 P22748 1/20 0.42
ERN1 O75460 1/20 0.42
LMNA P02545 3/20 0.41
MAPT P10636 1/20 0.41
TYR P14679 1/20 0.40
CDK4 P11802 1/20 0.40
CCND1 P24385 1/20 0.40
JUN P05412 1/20 0.40
NFE2L2 Q16236 1/20 0.40
BLM P54132 2/20 0.38
TDP1 Q9NUW8 2/20 0.38
NR1I2 O75469 1/20 0.38
PTGS1 P23219 1/20 0.38
ADRA1A P35348 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Salicyladehyde SCHEMBL28475111 0.88 TRIM24 (0.64) TRIM24TRIM33CA1CA2NFKB1
Valine SCHEMBL9178645 0.86 SLC7A5 (0.47) TRIM24TRIM33SLC7A5CA1CA2
Salicyladehyde SCHEMBL25208874 0.84 TRIM24 (0.69) TRIM24TRIM33CA1CA2NFKB1
Valine SCHEMBL1357700 0.80 SLC7A5 (0.56) SLC7A5TYRMEN1KMT2ASLC1A3
Salicyladehyde SCHEMBL9084251 0.79 TRIM24 (0.78) TRIM24TRIM33CA1CA2NFKB1
Salicyladehyde SCHEMBL27791581 0.78 TRIM24 (0.86) TRIM24TRIM33CA1CA2NFKB1
Salicyladehyde SCHEMBL27614253 0.78 TRIM24 (0.95) TRIM24TRIM33CA1CA2NFKB1
Salicyladehyde SCHEMBL1070652 0.78 TRIM24 (0.64) TRIM24TRIM33CA1CA2NFKB1
Tropolone SCHEMBL9772327 0.78 DBH (0.57) SLC7A5CA1CA2LMNAMAPT
Salicyladehyde SCHEMBL10428023 0.78 TRIM24 (0.64) TRIM24TRIM33CA1CA2NFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1631296-B1 2,3,4,5-TETRAHYDROBENZO¬F|¬1,4|OXAZEPINE-5-CARBOXYLIC ACID AMIDE DERIVATIVES AS GAMMA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE HOFFMANN LA ROCHE (CH) 2007-04-25 EP disclosed
EP-1631296-A1 2,3,4,5-TETRAHYDROBENZO[F][1,4]OXAZEPINE-5-CARBOXYLIC ACID AMIDE DERIVATIVES AS GAMMA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE F. HOFFMANN-LA ROCHE AG (CH) 2006-03-08 EP disclosed
WO-2004100958-A1 2, 3, 4, 5-TETRAHYDROBENZO[F][1, 4]OXAZEPINE-5-CARBOXYLIC ACID AMIDE DERIVATIVES AS GAMMA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER’S DISEASE F. HOFFMANN-LA ROCHE AG (CH) 2004-11-25 WO disclosed